Literature DB >> 23178688

Atrial tachycardia provoked in the presence of activating autoantibodies to β2-adrenergic receptor in the rabbit.

Hongliang Li1, Benjamin J Scherlag, David C Kem, Caitlin Zillner, Shailesh Male, Sorkko Thirunavukkarasu, Xiaohua Shen, Jan V Pitha, Madeleine W Cunningham, Ralph Lazzara, Xichun Yu.   

Abstract

BACKGROUND: A recent clinical study of patients with inappropriate sinus tachycardia reported that autoantibodies to β-adrenergic receptors (β2ARs) could act as agonists to induce atrial arrhythmias.
OBJECTIVE: To test the hypothesis that activating autoantibodies to the β2AR in the rabbit atrium are arrhythmogenic.
METHODS: Five New Zealand white rabbits were immunized with a β2AR second extracellular loop peptide to raise β2AR antibody titers. A catheter-based electrophysiologic study was performed on anesthetized rabbits before and after immunization. Arrhythmia occurrence was determined in response to burst pacing before and after the infusion of acetylcholine in incremental concentrations of 10 μM, 100 μM, and 1 mM at 1 mL/min.
RESULTS: In the preimmune studies when β2AR antibody titers were undetectable, of a total of 20 events, only 3 episodes of nonsustained (<10 seconds) atrial arrhythmias were induced. In the postimmune studies when β2AR antibody titers ranged from 1:160,000 to 1:1.28 million, burst pacing induced 10 episodes of nonsustained or sustained (≥10 seconds) arrhythmias in 20 events (P = .04 vs preimmune; χ(2) and Fisher exact test). Taking into account only the sustained arrhythmias, there were 6 episodes in 20 events in the postimmune studies compared with 0 episodes in 20 events in the preimmune studies (P = .02). Immunized rabbits demonstrated immunoglobulin G deposition in the atria, and their sera induced significant activation of β2AR in transfected cells in vitro compared to the preimmune sera.
CONCLUSIONS: Enhanced autoantibody activation of β2AR in the rabbit atrium leads to atrial arrhythmias mainly in the form of sustained atrial tachycardia. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178688      PMCID: PMC3723380          DOI: 10.1016/j.hrthm.2012.11.010

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  29 in total

Review 1.  Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy.

Authors:  G Wallukat; E Nissen; R Morwinski; J Müller
Journal:  Herz       Date:  2000-05       Impact factor: 1.443

2.  Beta-adrenergic and muscarinic cholinergic receptor densities in the human sinoatrial node: identification of a high beta 2-adrenergic receptor density.

Authors:  M D Rodefeld; S L Beau; R B Schuessler; J P Boineau; J E Saffitz
Journal:  J Cardiovasc Electrophysiol       Date:  1996-11

3.  Characterization of beta-1 and beta-2 adrenoceptors in guinea pig atrium: functional and receptor binding studies.

Authors:  P Molenaar; R J Summers
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

Review 4.  Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies.

Authors:  A L P Caforio; L Daliento; A Angelini; S Bottaro; A Vinci; G Dequal; F Tona; S Iliceto; G Thiene; W J McKenna
Journal:  Lupus       Date:  2005       Impact factor: 2.911

Review 5.  Connective tissue diseases and cardiac rhythm disorders: an overview.

Authors:  Pietro Enea Lazzerini; Pier Leopoldo Capecchi; Francesca Guideri; Maurizio Acampa; Mauro Galeazzi; Franco Laghi Pasini
Journal:  Autoimmun Rev       Date:  2005-12-09       Impact factor: 9.754

6.  Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy.

Authors:  M Iwata; T Yoshikawa; A Baba; T Anzai; H Mitamura; S Ogawa
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

Review 7.  Molecular basis of arrhythmias.

Authors:  Manish Shah; Fadi G Akar; Gordon F Tomaselli
Journal:  Circulation       Date:  2005-10-18       Impact factor: 29.690

8.  Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction.

Authors:  P A Chiale; I Ferrari; E Mahler; M A Vallazza; M V Elizari; M B Rosenbaum; M J Levin
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

Review 9.  Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance.

Authors:  Alida L P Caforio; Niall J Mahon; Francesco Tona; William J McKenna
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

10.  Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.

Authors:  Akiyasu Baba; Tsutomu Yoshikawa; Yukiko Fukuda; Takashi Sugiyama; Megumi Shimada; Makoto Akaishi; Kanji Tsuchimoto; Satoshi Ogawa; Michael Fu
Journal:  Eur Heart J       Date:  2004-07       Impact factor: 29.983

View more
  10 in total

1.  Atrial tachyarrhythmias induced by the combined effects of β1/2-adrenergic autoantibodies and thyroid hormone in the rabbit.

Authors:  Hongliang Li; Benjamin J Scherlag; David C Kem; Alexandria Benbrook; Ling Zhang; Bing Huang; Madeleine W Cunningham; Ralph Lazzara; Xichun Yu
Journal:  J Cardiovasc Transl Res       Date:  2014-06-06       Impact factor: 4.132

Review 2.  Inflammation and the pathogenesis of atrial fibrillation.

Authors:  Yu-Feng Hu; Yi-Jen Chen; Yenn-Jiang Lin; Shih-Ann Chen
Journal:  Nat Rev Cardiol       Date:  2015-01-27       Impact factor: 32.419

3.  Activating autoantibodies to the β1/2-adrenergic and M2 muscarinic receptors associate with atrial tachyarrhythmias in patients with hyperthyroidism.

Authors:  Allison Galloway; Hongliang Li; Megan Vanderlinde-Wood; Muneer Khan; Alexandria Benbrook; Campbell Liles; Caitlin Zillner; Veitla Rao; Madeleine W Cunningham; Xichun Yu; David C Kem
Journal:  Endocrine       Date:  2014-12-11       Impact factor: 3.633

4.  Implications of a vasodilatory human monoclonal autoantibody in postural hypotension.

Authors:  Hongliang Li; Jonathan Zuccolo; David C Kem; Caitlin Zillner; Jiyeon Lee; Kenneth Smith; Judith A James; Madeleine W Cunningham; Xichun Yu
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

5.  A peptidomimetic inhibitor suppresses the inducibility of β1-adrenergic autoantibody-mediated cardiac arrhythmias in the rabbit.

Authors:  Hongliang Li; Ling Zhang; Bing Huang; Vineet Veitla; Benjamin J Scherlag; Madeleine W Cunningham; Christopher E Aston; David C Kem; Xichun Yu
Journal:  J Interv Card Electrophysiol       Date:  2015-10-07       Impact factor: 1.900

6.  Inducible cardiac arrhythmias caused by enhanced β1-adrenergic autoantibody expression in the rabbit.

Authors:  Hongliang Li; Benjamin J Scherlag; David C Kem; Alexandria Benbrook; Xiaohua Shen; Madeleine W Cunningham; Ralph Lazzara; Christopher E Aston; Xichun Yu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-22       Impact factor: 4.733

7.  The Propensity for Inducing Atrial Fibrillation: A Comparative Study on Old versus Young Rabbits.

Authors:  Hongliang Li; Benjamin J Scherlag; David C Kem; Caitlin Zillner; Shailesh Male; Sorkko Thirunavukkarasu; Xiaohua Shen; Alexandria Benbrook; Jan V Pitha; Ralph Lazzara; Xichun Yu
Journal:  J Aging Res       Date:  2014-03-02

8.  PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury.

Authors:  Chen Fang; Kun Zuo; Kaicheng Jiao; Xiaoming Zhu; Yuan Fu; Jiuchang Zhong; Li Xu; Xinchun Yang
Journal:  Biomolecules       Date:  2022-08-15

9.  Adrenergic Autoantibody-Induced Postural Tachycardia Syndrome in Rabbits.

Authors:  Hongliang Li; Gege Zhang; Liping Zhou; Zachary Nuss; Marci Beel; Brendon Hines; Taylor Murphy; Jonathan Liles; Ling Zhang; David C Kem; Xichun Yu
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

Review 10.  The Role of Autoantibodies in Arrhythmogenesis.

Authors:  Jin Li
Journal:  Curr Cardiol Rep       Date:  2020-11-25       Impact factor: 2.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.